Mass Tort brief
Infant Formula Defense Wins and Mass Settlement Restructurings
Federal trial victories reshape infant formula liabilities while J&J, Meta, and pharma makers face mounting mass tort pressures.
Mass Tort
Winning the first federal bellwether trial breaks plaintiff momentum in the infant formula litigation — giving Reckitt strong leverage to resolve remaining claims without a multi-billion dollar global settlement.
BackgroundMore than 800 lawsuits are centralized in federal multidistrict litigation in Illinois alleging cow's milk-based infant formulas cause severe intestinal disease in premature infants. Previous state court trials yielded massive jury awards against formula makers.
- US District Judge Rebecca Pallmeyer presided over the two-week federal bellwether trial in Chicago, establishing the initial federal evidentiary baseline.
- The complete defense win leaves Mead Johnson with no active adverse jury verdicts standing in the nationwide litigation after prior state awards were overturned.
- Shares of parent company Reckitt Benckiser rose in European trading following the verdict as investors priced in reduced global litigation risk.
Mass Tort
J&J proposing a $5.5 billion settlement as its chief legal strategist departs signals the health giant is abandoning corporate bankruptcy tactics to settle its massive talc liability.
BackgroundJ&J faces over 68,000 centralized cases in New Jersey federal court alleging its talc-based baby powder caused ovarian cancer and mesothelioma. Higher courts have repeatedly rejected previous attempts to resolve claims via Texas two-step bankruptcy filings.
- The proposed $5.5 billion settlement framework requires a 95% claimant participation threshold to take effect and bindingly discharge future claims.
- Litigation chief Erik Haas departed J&J to join law firm Linklaters after leading the company's mass tort bankruptcy defense strategy.
- A Louisiana state jury separately ordered J&J to pay a $10 million verdict in an individual talc mesothelioma lawsuit, underscoring ongoing trial exposure.
Mass Tort
Excluding complex medical histories from initial hair relaxer trials ensures early jury verdicts will reflect core product liability claims — setting a clean benchmark for global settlement talks.
BackgroundThousands of women filed product liability lawsuits against cosmetic manufacturers alleging chemical hair relaxers caused uterine and ovarian cancers. Bellwether trials test jury reactions to establish settlement valuation benchmarks.
- Magistrate Judge Beth Jantz issued Case Management Order 28 setting expert discovery deadlines for final trial preparation across the narrowed pool.
- Claims involving confounding factors like overlapping talc exposure or dual cancer diagnoses were removed from initial trial consideration.
- Selection of the final five bellwether cases prepares the multidistrict litigation for initial federal jury trials scheduled for late 2026.
Mass Tort
Mass Tort